Tai-Hsien Ou Yang

Tai-Hsien Ou Yang

Auto-generated profile, based on publicly available information

Tai-Hsien Ou Yang

Department of Systems Biology, Columbia University, New York, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2013 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
WCWei-Yi Cheng
Wei-Yi Cheng
TYTai-Hsien Ou Yang
Tai-Hsien Ou Yang
DADimitris Anastassiou
Dimitris Anastassiou
A computational modeling approach that combined several molecular features yielded a robust breast cancer prognostic model that was independently validated in a new patient data set.

21 February 2013 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
WCWei-Yi Cheng
Wei-Yi Cheng
TYTai-Hsien Ou Yang
Tai-Hsien Ou Yang
DADimitris Anastassiou
Dimitris Anastassiou
Mining gene expression profiles has proven valuable for identifying signatures serving as surrogates of cancer phenotypes. However, the similarities of such signatures across different cancer types have not been strong enough to conclude that they represent a universal biological mechanism shared among multiple cancer types. Here we present a computational method for generating signatures using an iterative process that converges to one of several precise attractors defining signatures representing biomolecular events, such as cell transdifferentiation or the presence of an amplicon. By analyzing rich gene expression datasets from different cancer types, we identified several such biomolecular events, some of which are universally present in all tested cancer types in nearly identical form. Although the method is unsupervised, we show that it often leads to attractors with strong phenotypic associations. We present several such multi-cancer attractors, focusing on three that are prominent and sharply defined in all cases: a mesenchymal transition attractor strongly associated with tumor stage, a mitotic chromosomal instability attractor strongly associated with tumor grade, and a lymphocyte-specific attractor. Cancer is known to be characterized by several unifying biological capabilities or “hallmarks.” However, attempts to computationally identify patterns, such as gene expression signatures, shared across many different cancer types have been largely unsuccessful. A typical approach has been to classify samples into mutually exclusive subtypes, each of which is characterized by a particular gene signature. Although occasional similarities of such signatures in different cancer types exist, these similarities have not been sufficiently strong to conclude that they reflect the same biological event. By contrast, we have developed a computational methodology that has identified some signatures of co-expressed genes exhibiting remarkable similarity across many different cancer types. These signatures appear as stable “attractors” of an iterative computational procedure that tends to collect mutually associated genes, so that its convergence can point to the core (“heart”) of the underlying biological co-expression mechanism. One of these “pan-cancer” attractors corresponds to a transdifferentiation of cancer cells empowering them with invasiveness and motility. Another represents a mitotic chromosomal instability of cancer cells. A third attractor is lymphocyte-specific.

9 January 2020 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
DPDream Smc-Het Participants
Dream Smc-Het Participants
ASAdriana Salcedo
Adriana Salcedo
MTMaxime Tarabichi
Maxime Tarabichi
SEShadrielle Melijah G. Espiritu
Shadrielle Melijah G. Espiritu
ADAmit G. Deshwar
Amit G. Deshwar
PBPaul C. Boutros
Paul C. Boutros

1 September 2011 in Journal of Neuroscience Methods
Verified
Journal Article
Closed access
TOTai-Hsien Ou-Yang
Tai-Hsien Ou-Yang
MTMeng-Li Tsai
Meng-Li Tsai
CYChen-Tung Yen
Chen-Tung Yen
TLTa-Te Lin
Ta-Te Lin

15 March 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
SDSebastian Dziadek
Sebastian Dziadek
AKAnton Kraxner
Anton Kraxner
WCWei-Yi Cheng
Wei-Yi Cheng
TYTai-Hsien Ou Yang
Tai-Hsien Ou Yang
MFMike Flores
Mike Flores
JCJehad Charo
Jehad Charo
Introduction: Fibroblast activation protein (FAP) is predominantly upregulated in various tumor microenvironments and scarcely expressed in normal tissues.Methods: We analyzed FAP across 1216 tissue samples covering 23 tumor types and 70 subtypes.Results: Elevated FAP levels were notable in breast, pancreatic, esophageal, and lung cancers. Using immunohistochemistry and RNAseq, a correlation between FAP gene and protein expression was found. Evaluating FAP’s clinical significance, we assessed 29 cohorts from 12 clinical trials, including both mono and combination therapies with the PD-L1 inhibitor atezolizumab and chemotherapy. A trend links higher FAP expression to poorer prognosis, particularly in RCC, across both treatment arms. However, four cohorts showed improved survival with high FAP, while in four others, FAP had no apparent survival impact.Conclusions: Our results emphasize FAP’s multifaceted role in therapy response, suggesting its potential as a cancer immunotherapy biomarker.

1 October 2015 in Computers and Electronics in Agriculture
Verified
Journal Article
Closed access
TOTai-Hsien Ouyang
Tai-Hsien Ouyang
En-cheng YangEn-cheng Yang
En-cheng Yang
JJJoe-Air Jiang
Joe-Air Jiang
TLTa-Te Lin
Ta-Te Lin